Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

APhA BRINGS IN HHS ADVISOR, KEVILLE, FOR GOVT. AFFAIRS; FOUR VPs REASSIGNED

Executive Summary

A top staff reorganization at the American Pharmaceutical Assn. (APhA) is highlighted by the recruitment of Dorothy Keville from HHS to be the assn's director of govt. affairs and by the establishment of two coordinating groups "to improve staff communication and to develop a more coordinated approach to identifying issues, solving problems, and carrying out programs." APhA President Jack Schlegel announced the staff reorganization -- his first effort to redesign the assn. staff structure -- on Oct. 19. Schlegel was chosen to head the pharmacy assn. in early April. The assn. is moving to a set-up of staff directors and eliminating four VP-level positions. The positions were established by ex-APhA President William Apple several months before he died in December 1983. The APhA staff directors will oversee areas of business, communications, education, liaison/state-relations, pharmacy intelligence, professional affairs, and scientific affairs. The position of associate general counsel is also on the level of a staff director. For the past four years, Keville has been an advisor to HHS Sectys. Patricia Harris, Richard Schweiker and Margaret Heckler on natl. health policy development. Schlegal said she will "help move APhA more aggressively into the arena of govt. affairs and federal liaison." The assn.'s new govt. affairs director is a graduate of Antioch University in Cambridge, Mass., with a 1978 M. Ed. degree in human and social services. She has been HHS health policy coordinator for programs including alcohol abuse, drug abuse, mental health, maternal and child health, and emergency medical service. Keville has served as departmental liaison on consumer affairs with FDA, as well as liaison with the State Dept. on internatl. narcotics matters. She developed and managed the Federal Interagency Task Force on Food & Shelter Initiative for the Homeless, comprising 13 federal agencies and requiring close coordination with the White House. In Boston, she had worked for the Dept. of Mental Health for five years.

You may also be interested in...



Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance

FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials

Shire Hopes To Sow Future Deals With $50M Venture Fund

Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth

UsernamePublicRestriction

Register

ID014775

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel